Simcere UK

Simcere Pharma is the European arm of Simcere Pharmaceutical Group, a prominent Chinese pharmaceutical company with over 5000 employees. Renowned for its innovation in drug development, Simcere is focused on therapeutic areas such as oncology, CNS, autoimmune and infectious disease, as well as technology platforms including cell therapy and artificial intelligence. With a significant global presence, including the US and Europe, the company is actively seeking innovative drug candidates. The UK subsidiary, Simcere UK Ltd, serves as a local talent recruitment hub and facilitates business development within Europe. Established in 1995 and headquartered in the United Kingdom, Simcere attracted a noteworthy CNY970.00MPost-IPO Equity investment from investors including SDIC Fund Management, Apricot Capital, Zhongshen New Venture, Zhonghe Capital as of 27 February 2024. This investment is a testament to the company's expansion and potential in the global pharmaceutical market.